Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer

Clinical trial NCT01091454 · COMPLETED

Trial details

NCT number: NCT01091454
Sponsor: Alliance for Clinical Trials in Oncology
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Triple-negative Breast Cancer

Start date: 2010-06-01
Primary completion: 2012-06-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.